flexbumin- albumin human injection, solution
takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.05 g in 1 ml - flexbumin 5% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia and cardiopulmonary bypass surgery. flexbumin 5% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 25% albumin should be used.4,6 flexbumin 5% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 5% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 5% is indicated in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace protein loss which accompanies any severe burn.4,6 preoperative dilution of blood using albumin and crystalloid can be used in cardiopulmonary bypass surgery. flexbumin 5% is indicated a
flexbumin- albumin human solution
takeda pharmaceuticals america, inc. - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin human 0.20 g in 1 ml - flexbumin 20% [albumin (human)] is indicated for hypovolemia, hypoalbuminemia, cardiopulmonary bypass surgery, and hemolytic disease of the newborn (hdn). flexbumin 20% [albumin (human)] is indicated for reversing hypovolemia. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% albumin should be used.4,6 flexbumin 20% is indicated for patients with hypoalbuminemia resulting from one or more of the following:5 flexbumin 20% is indicated for patients with hypoalbuminemia accompanying severe injuries, infections or severe pancreatitis that cannot be quickly reversed and nutritional supplements fail to restore serum albumin levels. burns after the first 24 hours, flexbumin 20% is indicated, in conjunction with appropriate crystalloid therapy, for the treatment of oncotic deficits following extensive burns and to replace the protein loss which accompanies any severe burn.4,6 adult respiratory distress syndrome (ards) flexbumin 20% is indicated, in conjunctio
zenalb 20 human albumin solution 20% wv
euro asia medico pte. ltd. - albumin (human) - injection - 20% w/v - albumin (human) 20% w/v
zenalb 4.5 human albumin solution 4.5% wv
euro asia medico pte. ltd. - albumin (human) - injection - 4.5% w/v - albumin (human) 4.5% w/v
uman albumin solution for infusion 200 gl
duo medical pte. ltd. - human albumin (human plasma protein containing at least 95% albumin) - infusion, solution - 200 g/l - human albumin (human plasma protein containing at least 95% albumin) 200 g/l
human albumin 20% biotest low salt content
biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human plasma, protein - solution for infusion - human plasma protein 200 g/l - blood substitutes and perfusion solutions
zenalb-20 50ml (20% human albumin)
germax sdn. bhd. - albumin human -
flexbumin 20% albumin (human) usp 20% solution
takeda pharmaceuticals (asia pacific) pte. ltd. - albumin (human) - injection, solution - 20g/100ml - albumin (human) 20g/100ml
flexbumin 25% albumin (human) usp 25% solution
takeda pharmaceuticals (asia pacific) pte. ltd. - albumin (human) - injection, solution - 25 g/100 ml - albumin (human) 25 g/100 ml
uman albumin 200g/l solution for infusion (50ml vial)
kedrion s.p.a loc. ai conti, 55051 castelvecchio pascoli, barga - lucca, italy - albumin, human - solution for infusion - albumin, human 20 g/100ml - blood substitutes and perfusion solutions